NO20044628L - Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler - Google Patents

Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler

Info

Publication number
NO20044628L
NO20044628L NO20044628A NO20044628A NO20044628L NO 20044628 L NO20044628 L NO 20044628L NO 20044628 A NO20044628 A NO 20044628A NO 20044628 A NO20044628 A NO 20044628A NO 20044628 L NO20044628 L NO 20044628L
Authority
NO
Norway
Prior art keywords
cell surface
containing cell
surface recognition
immunoglobulin domains
recognition molecules
Prior art date
Application number
NO20044628A
Other languages
English (en)
Norwegian (no)
Inventor
Christine Power
Andrew Robert Davids
Richard Joseph Fagan
Christopher Benjamin Phelps
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20044628L publication Critical patent/NO20044628L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
NO20044628A 2002-04-30 2004-10-27 Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler NO20044628L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0209884.6A GB0209884D0 (en) 2002-04-30 2002-04-30 Proteins
PCT/GB2003/001851 WO2003093316A2 (en) 2002-04-30 2003-04-30 Immunoglobulin-domain containing cell surface recognition molecules

Publications (1)

Publication Number Publication Date
NO20044628L true NO20044628L (no) 2004-12-29

Family

ID=9935806

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044628A NO20044628L (no) 2002-04-30 2004-10-27 Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler

Country Status (16)

Country Link
US (1) US7622555B2 (enExample)
EP (1) EP1499640A2 (enExample)
JP (1) JP2006502702A (enExample)
KR (1) KR20050008699A (enExample)
CN (1) CN1665840A (enExample)
AU (1) AU2003229961B2 (enExample)
BR (1) BR0309638A (enExample)
CA (1) CA2483038A1 (enExample)
EA (1) EA007985B1 (enExample)
GB (1) GB0209884D0 (enExample)
IL (1) IL164777A0 (enExample)
MX (1) MXPA04010674A (enExample)
NO (1) NO20044628L (enExample)
RS (1) RS92704A (enExample)
WO (1) WO2003093316A2 (enExample)
ZA (1) ZA200408453B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0326393D0 (en) * 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
JP2008540385A (ja) * 2005-05-06 2008-11-20 ラボラトワール セローノ ソシエテ アノニム 疾患を治療するための免疫グロブリンドメイン含有細胞表面認識分子の使用
CN100402551C (zh) * 2006-04-14 2008-07-16 中国科学院长春应用化学研究所 β2-微球蛋白的抗原表位及应用
WO2008019477A1 (en) 2006-08-17 2008-02-21 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
DK2164514T3 (en) 2007-05-21 2017-02-27 Alderbio Holdings Llc Antibodies to IL-6 and its use
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US7906117B2 (en) 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
EP2504032A4 (en) 2009-11-24 2013-06-19 Alderbio Holdings Llc IL-6 ANTAGONISTS FOR PREVENTING OR TREATING THROMBOSIS
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
US8992908B2 (en) 2010-11-23 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of oral mucositis
US11530277B2 (en) 2016-04-20 2022-12-20 Regeneron Pharmaceuticals, Inc. Compositions and methods for making antibodies based on use of an expression-enhancing locus
CN107526942B (zh) * 2017-07-18 2021-04-20 中山大学 生命组学序列数据的反向检索方法
CN112592973A (zh) * 2020-12-30 2021-04-02 昆明医科大学第一附属医院 单核苷酸多态性rs1553607744在检测着色性干皮病基因中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420526B1 (en) * 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
GB2331666A (en) * 1997-11-20 1999-05-26 Dsc Telecom Lp Subscriber Terminal for a Wireless Telecommunications System
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
WO2001054477A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
JP2004530409A (ja) * 2000-10-27 2004-10-07 インサイト・ゲノミックス・インコーポレイテッド 膜貫通タンパク質
JP2004535759A (ja) * 2000-11-16 2004-12-02 インサイト・ゲノミックス・インコーポレイテッド 免疫グロブリンスーパファミリタンパク質
WO2004007672A2 (en) 2002-07-12 2004-01-22 Nuvelo, Inc. Methods and materials relating to novel polypeptides and polynucleotides
CA2500521A1 (en) 2002-10-02 2004-09-23 Nuvelo, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
KR20050008699A (ko) 2005-01-21
WO2003093316A3 (en) 2004-02-12
RS92704A (sr) 2006-12-15
WO2003093316A2 (en) 2003-11-13
EA200401453A1 (ru) 2005-06-30
JP2006502702A (ja) 2006-01-26
EA007985B1 (ru) 2007-02-27
AU2003229961B2 (en) 2009-02-19
CN1665840A (zh) 2005-09-07
CA2483038A1 (en) 2003-11-13
IL164777A0 (en) 2005-12-18
US7622555B2 (en) 2009-11-24
GB0209884D0 (en) 2002-06-05
ZA200408453B (en) 2006-07-26
US20040204352A1 (en) 2004-10-14
AU2003229961A1 (en) 2003-11-17
BR0309638A (pt) 2005-03-01
MXPA04010674A (es) 2005-02-17
EP1499640A2 (en) 2005-01-26

Similar Documents

Publication Publication Date Title
US12292446B2 (en) Kits for analysis using nucleic acid encoding and/or label
WO2003093316A3 (en) Immunoglobulin-domain containing cell surface recognition molecules
US20200348307A1 (en) Methods and compositions for polypeptide analysis
US20220227889A1 (en) Methods and reagents for cleavage of the n-terminal amino acid from a polypeptide
JP2025527266A (ja) 重合性分子の結合を介したタンパク質の配列決定
DK1673475T3 (da) Sammensætninger til diagnose og terapi af sygdomme, som er forbundet med aberrant ekspression af futriner (R-Spondiner) og/eller Wnt
DE602004021836D1 (de) Meg1-endospermspezifische promotoren und gene
CN120604125A (zh) 使用二硫代酯和硫代氨基甲酰基氨基酸反应性基团的单分子肽测序
WO2025166050A1 (en) Nanopore-based sequencing of peptides
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
NO20070780L (no) Celloverflateprotein.
ATE482976T1 (de) Defensinproteine
MX2007005054A (es) Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax.
EA200600956A1 (ru) Молекулы-антагонисты цитокинов
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein
DE602004015468D1 (de) Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält
NO20053512L (no) IL-8-liknende proteiner
EP1801232A4 (en) METHOD FOR SCREENING A TRANSMEMBRANENZYMHEMMSTOFFS
DE602004024300D1 (de) Anti-BAMBI Antikörper oder RNA zur Diagnose und Therapie bei Dickdarm- oder Leberkrebs
ATE512983T1 (de) Rezeptor für das tgr3-like protein
NO20052958L (no) Spleisevariant av humant placentalt veksthormon
WO2007049065A3 (en) Vwfa, collagen and kunitz domain containing protein
NO20053574L (no) Spleisevarianter av LGR6
DE10345010A1 (de) Verwendung von an Nifie14 bindenden Substanzen zur Diagnose und Behandlung von Krebs
DE60035857D1 (de) Nukleinsäure- und aminosäuresequenzen von durch hämoglobin induzierbaren genen aus candida albicans und die verwendung dieser sequenzen in reagenzien zur diagnose von disseminierten candida albicans infektionen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application